Dermatomyositis - 37 Studies Found

Completed : Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
: Dermatomyositis
: 2015-06-02
:
  • Drug: JBT-101 Part A: 20 mg on
Terminated : A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis
: Dermatomyositis
: 2010-04-06
: Drug: Apremilast Apremilast 20mg PO BID
Terminated : Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
: Juvenile Dermatomyositis
: 2006-05-09
:
  • Drug: 3 MPDN pulse + PDN 3 met
Completed : Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)
: Dermatomyositis
: 2016-03-11
:
  • Drug: Octagam 10% Patients to

Completed : Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
:
  • Dermatomyositis
  • Polymyositis

: 2013-07-05
: Drug: Adrenocorticotropic Hormone Gel H.P. Acthar Gel 80 units will be self-administered subcutaneously
Completed : A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis
: DERMATOMYOSITIS OR POLYMYOSITIS
: 2007-09-20
:
  • Biological: MEDI-545

Completed : Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
:
  • Dermatomyositis
  • Polymyositis

: 2014-01-17
:
  • Drug: tocilizumab given at a d
Completed : Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM)
:
  • Polymyositis
  • Dermatomyositis

: 2006-06-08
:
  • Drug: GB-0998 8 mL (400 mg of

Enrolling by invitation : Dermatomyositis and Polymyositis Registry
:
  • Dermatomyositis
  • Polymyositis

: 2012-07-06
: Drug: Acthar Physicians will prescribe Acthar at their own discretion; however the recommended dose is 8
Completed : Hand Function in Patients With Poly- or Dermatomyositis
:
  • Polymyositis
  • Dermatomyositis

: 2009-03-19
<<< Previous | Next >>>